Skip to content

SCREENER CHART SD50 CALENDAR NEWS

...

Obsidian Therapeutics Inc. (OBX) Stock · SELL | LOPJLB

Obsidian Therapeutics Inc. (OBX)

Healthcare · Biotechnology · NASDAQ · US

$13.84+1.84%Close

SELL

OBX▼ SELL

$13.84+1.84%

Overview FinancialsFin EarningsEarn Analyst & RatingsAnalyst News Holders & ETFsHold Options

Key stats

Short interest · FINRA settlement 2026-09-15

Market cap: $14M
Beta: 2.60
Short % float: 51.28%

Days to cover: 1.0
SI change: +210.7%

1W: +3.52%
1M: -19.02%

vs SPY 1W: +2.31%
vs SPY 1M: -19.48%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

A clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies for the treatment of patients with solid tumors. Its proprietary cytoDRiVEÂ® technology is designed to precisely…

Employees: 87
Headquarters: US
Founded: 2026
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 1.0M

obsidiantx.com ↗

Key executives

Madan Jagasia — President, CEO & Director

Parameswaran Hari — Chief Medical Officer

Dana Alexander — Chief Technical Officer

SEC filings

EDGAR · CIK 21306060 · OBX

All filings
10-K
10-Q
8-K
Form 4

Analyst consensus

L $32.00Avg $37.00H $42.00

Target$37.00+167.34%

Last$13.84

Company news

gurufocus.com · 4d ago

Obsidian Therapeutics to Present Updated Amsoki-cel (OBX-115) Phase 1/2 Data in Advanced Melanoma at SITC 2026 Annual Meeting

businesswire.com · 4d ago

Obsidian Therapeutics to Present Updated Amsoki-cel (OBX-115) Phase 1/2 Data in Advanced Melanoma at SITC 2026 Annual Meeting

defenseworld.net · 8d ago

Obsidian Therapeutics (NASDAQ:OBX) Short Interest Update

seekingalpha.com · 25d ago

Obsidian Therapeutics: A $1.1 Billion Valuation Leaves Little Margin For Error

247wallst.com · 61d ago

Here Are Thursday’s Top Wall Street Analyst Research Calls: AppLovin, Charles River, Global Payments, HubSpot, Insulet Corporation, Roper Technologies, Sabra Health Care, Western Digital, Zillow Group, and More

businesswire.com · 62d ago

Obsidian Therapeutics Announces First Patient Enrolled in the Registration-enabling Cohort of Phase 1/2 Agni-01 Study Evaluating Amsoki-cel (OBX-115) in Advanced Melanoma

businesswire.com · 64d ago

Obsidian Therapeutics Completes Closing of Transaction with Galera Therapeutics and Previously Announced Private Placement of $350 Million

Market news & ticker search · RSS for OBX

LOPJLB

Independent quant research on U.S. equities & ETFs. Not personalized advice.

Product

Screener Chart Compare SD50 Thesis News Calendar

Desk

Market Heatmap Market Hours FOMC Desk Treasury Rates Congress Trades Prediction Markets

Research

How It Works Methodology Track Record Editorial Blog Changelog

Ledgers

Bull Spreads Cash-Secured Puts Covered Calls Long Puts Long Calls

Screeners

CEF Screener REIT Screener BDC Screener Preferred Screener Dividend Screener ETF Screener Crypto Screener S&P 500 Screener

Company

Pricing About Contact

Agents

GitHub·Research Chat·MCPENT·Developers

© 2026 LOPJLB Research. All rights reserved.

@lopjlb contact@lopjlb.com

RANGE

LOPJLB.COM

OHLC🔒EMALEVELS🔒STOP🔒FLIP🔒52WSIGNALS🔒BUY🔒SELL🔒EXH🔒EXH ZONE